Search hospitals > Virginia > Norfolk
Sentara Norfolk General Hospital
Claim this profileNorfolk, Virginia 23507
Global Leader in Heart Failure
Global Leader in Atrial Fibrillation
Conducts research for Aortic Valve Stenosis
Conducts research for Coronary Artery Disease
Conducts research for Aortic Stenosis
215 reported clinical trials
25 medical researchers
Summary
Sentara Norfolk General Hospital is a medical facility located in Norfolk, Virginia. This center is recognized for care of Heart Failure, Atrial Fibrillation, Aortic Valve Stenosis, Coronary Artery Disease, Aortic Stenosis and other specialties. Sentara Norfolk General Hospital is involved with conducting 215 clinical trials across 284 conditions. There are 25 research doctors associated with this hospital, such as Paul Mahoney, MD, David Dexter, MD, Jean Panneton, MD, and Joseph Newton, MD.Top PIs
Paul Mahoney, MDSentara Norfolk General Hospital7 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Mitral Regurgitation
18 reported clinical trials
29 drugs studied
David Dexter, MDSentara Vascular Specialists4 years of reported clinical research
Studies Thrombus
Studies Venous Thrombosis
14 reported clinical trials
13 drugs studied
Jean Panneton, MDSentara Medical Group4 years of reported clinical research
Studies Ascending Aortic Aneurysm
Studies Abdominal Aortic Aneurysm
9 reported clinical trials
9 drugs studied
Joseph Newton, MDSentara Norfolk General Hospital6 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
6 reported clinical trials
11 drugs studied
Clinical Trials running at Sentara Norfolk General Hospital
Heart Failure
Mitral Regurgitation
Atrial Fibrillation
Lung Cancer
Abdominal Aortic Aneurysm
Deep Vein Thrombosis
Mitral Valve Regurgitation
Ascending Aortic Aneurysm
Pancreatic Cancer
Thrombus
Carillon Device
for Heart Failure with Mitral Regurgitation
This trial is testing a device called the Carillon Mitral Contour System, which helps the mitral valve in the heart work better. It targets patients with heart failure and a specific valve problem. The device reshapes the valve to improve its function and reduce symptoms.
Recruiting1 award N/A2 criteria
BI 690517 + Empagliflozin
for Heart Failure
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: * Vicadrostat and empagliflozin group: participants take vicadrostat and empagliflozin as tablets once a day. * Placebo and empagliflozin group: participants take placebo and empagliflozin as tablets once a day. Participants can stay in the study as long as they benefit from treatment and can tolerate it. During this time, they visit their doctors regularly. The doctors regularly check participants' health and take note of any unwanted effects. The study staff may also contact the participants by phone. Participants also regularly answer questions about their well-being. The study does not have a fixed duration. It continues until there is enough data to see if the treatment is working.
Recruiting1 award Phase 32 criteria
Omecamtiv Mecarbil
for Heart Failure
The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in patients with heart failure and severely reduced ejection fraction.
Recruiting1 award Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sentara Norfolk General Hospital?
Sentara Norfolk General Hospital is a medical facility located in Norfolk, Virginia. This center is recognized for care of Heart Failure, Atrial Fibrillation, Aortic Valve Stenosis, Coronary Artery Disease, Aortic Stenosis and other specialties. Sentara Norfolk General Hospital is involved with conducting 215 clinical trials across 284 conditions. There are 25 research doctors associated with this hospital, such as Paul Mahoney, MD, David Dexter, MD, Jean Panneton, MD, and Joseph Newton, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.